BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 18, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Nov. 19, 2025

Nov. 19, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Austrianova, Avant, Beone, Bio-Techne, Cytomed, Elektrofi, Halozyme, Harrow, Jazz, J&J, Klothea, Melt, Monod, Qualigen, TC Biopharm, Windtree, Zymeworks.
Read More

In the clinic for Nov. 19, 2025

Nov. 19, 2025
Clinical updates, including data readouts and publications: Artisan, Ascendis, Bioinvent, Can-Fite, Clearmind, Galmed, Genmab, Lipocine, Merck, Mycovia, Privo, Tule.
Read More

Financings for Nov. 19, 2025

Nov. 19, 2025
Biopharmas raising money in public or private financings, including: Angiex, Avanzanite, Bambusa, Fennec, Invivyd, Respirerx, Solve.
Read More

Appointments and advancements for Nov. 19, 2025

Nov. 19, 2025
New hires and promotions in the biopharma industry, including: Agenus, Akari, Apollomics, Medicinova, Nuvig, Serb, Zymeworks.
Read More

Appointments and advancements for Nov. 19, 2025

Nov. 19, 2025
New hires and promotions in the med-tech industry, including: Coaptech, Fluid Biomed, Hardy Diagnostics, Rockwell Medical.
Read More

Financings for Nov. 19, 2025

Nov. 19, 2025
Med-tech firms raising money in public or private financings, including: Autonomix Medical, Venstramedical.
Read More

In the clinic for Nov. 19, 2025

Nov. 19, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Archéon Médical, Deephealth, Exact Imaging, Intravent, Nexalin, Quanterix.
Read More

Other news to note for Nov. 19, 2025

Nov. 19, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3DR Labs, Beacon Biosignals, Bio-Techne, Cognita Imaging, Cryotherapeutics, Guided Therapeutics, Hangzhou Dongye Medical, Hyperfine, Locus Health, Mainz Biomed, Monod, Mosaic Clinical Technologies, Nano-X Imaging, Oncovanguard8, Owlet, Roche, Sapphiros, Spectrawave, Takeda, Vaso, Vasohealthcare, Yanshuo Medical.
Read More

Regulatory actions for Nov. 19, 2025

Nov. 19, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dexcom, Rapidai, Vesalio.
Read More

Regulatory actions for Nov. 18, 2025

Nov. 18, 2025
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Arcutis, Ascelia, Biogen, Bioinvent, Henlius, Incyte, Medicus, Obi, Organon, Sarepta, Silo, T-knife.
Read More
Previous 1 2 … 18 19 20 21 22 23 24 25 26 … 1718 1719 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 17, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing